OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
43
Results
Show all
Save search
Copy query
Show results for
Unknown
(35)
Proteomics
(8)
Organisms
Allexis
(8)
Arabidopsis thaliana
(8)
Callinectes sapidus
(8)
Danio rerio
(8)
Drosophila
(8)
Drosophila melanogaster
(8)
Entamoeba histolytica
(8)
Entamoeba histolytica HM-1:IMSS-A
(8)
Escherichia coli
(8)
Leishmania major strain Friedlin
(8)
Listeria monocytogenes
(8)
Medicago truncatula
(8)
Methylohalobius crimeensis 10Ki
(8)
Mus musculus
(8)
Mycobacterium tuberculosis
(8)
Oryza sativa Indica Group
(8)
Physcomitrium patens
(8)
Pseudomonas fluorescens WH6
(8)
Rattus norvegicus
(8)
Saccharomyces cerevisiae
(8)
Schizosaccharomyces pombe
(8)
Schizosaccharomyces pombe 972h-
(8)
Shigella
(8)
Shigella flexneri
(8)
Sinorhizobium meliloti BL225C
(8)
Solanum tuberosum
(8)
Staphylococcus aureus
(8)
Trypanosoma brucei
(8)
Trypanosoma cruzi
(8)
Zea mays
(8)
Repository
pride
(8)
Tissue
Tooth enamel
(3)
Peripheral blood mononuclear cell
(2)
Blood
(1)
Cell culture
(1)
Colon
(1)
Epithelial cell
(1)
Disease
Acute myeloid leukemia
(1)
Chronic myeloid leukemia
(1)
Colon cancer
(1)
Technology Type
Mass Spectrometry
(8)
Shotgun proteomics
(5)
Affinity purification coupled with mass spectrometry proteomics
(1)
Data-dependent acquisition
(1)
SWATH MS
(1)
Publication Date
2022
(2)
2019
(2)
2025
(1)
2023
(1)
2021
(1)
2018
(1)
Release Date
2018
(8)
2015
(4)
2019
(3)
2017
(3)
2016
(3)
2014
(3)
2024
(2)
2021
(2)
2020
(2)
2025
(1)
2023
(1)
2012
(1)
2011
(1)
2007
(1)
Lab affiliation
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry
(3)
Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria Joint Metabolome Facility, University and Medical University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria
(1)
Department of Hematology and Oncology, University of Tübingen, Germany
(1)
Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany
(1)
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany
(1)
University of Tübingen Interfaculty Institute for Cell Biology Department of Immunology Auf der Morgenstelle 15 72076 Tuebingen Germany
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Elevated high-sensitive cardiac troponin T in emergency department patients: insights from a retrospective descriptive cohort study.
Not available
S-EPMC11457446
|
biostudies-literature
Cite
ExMS: data analysis for HX-MS experiments.
Not available
S-EPMC3398505
|
biostudies-literature
Cite
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Not available
S-EPMC3487553
|
biostudies-literature
Cite
Quantification of dental macrowear using 3D occlusal surface topographic measurements in deciduous and permanent molars of children.
Not available
S-EPMC8360031
|
biostudies-literature
Cite
Child murder in the Early Bronze Age: proteomic sex identification of a cold case from Schleinbach, Austria.
Not available
S-EPMC7584537
|
biostudies-literature
Cite
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL).
Not available
S-EPMC4299203
|
biostudies-literature
Cite
Dasatinib overrides the differentiation blockage in a patient with mutant-
KIT
D816V positive CBFβ-MYH11 leukemia.
Not available
S-EPMC5837740
|
biostudies-literature
Cite
Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.
Not available
S-EPMC4565992
|
biostudies-literature
Cite
Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence.
Not available
S-EPMC5090218
|
biostudies-literature
Cite
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.
Not available
S-EPMC5889201
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
